Sapmaz Ersin, Çaylak Hasan, Kavaklı Kuthan, Gamsızkan Mehmet, Şirin Yusuf Sinan, Genç Onur
Department of Thoracic Surgery, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
Department of Pathology, Medicine Faculty of Düzce University, Düzce, Turkey.
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Sep 16;26(4):606-613. doi: 10.5606/tgkdc.dergisi.2018.16078. eCollection 2018 Oct.
This study aims to investigate the preventive effect of proanthocyanidin against ischemia-reperfusion injury after lung transplantation.
The study included 12 swines (weighing 35±5 kg) and separated into four groups. Groups 1 and 3 were identified as control groups and left upper lobectomy was performed. Groups 2 and 4 were identified as transplantation groups and left lower lobectomy and heterotransplantation were performed. Proanthocyanidin was only given to groups 3 and 4. Tissue samples were analyzed under light microscope and histopathological findings were recorded.
There was no statistically significant difference between control groups in terms of the numerical values of histopathological findings that include congestion (p=0.565), alveolar edema (p=0.197) and peribronchial inflammation (p=0.444). However, numerical values of acute cellular rejection were statistically significantly different between transplantation groups (p=0.048). Mean oxidative stress enzyme levels were higher in group 2 compared to group 4; however, the difference was not statistically significant (p>0.05).
According to the findings of our experimental study, proanthocyanidin can be safely used in lung transplantation based on its preventive effect in ischemia-reperfusion injury that may lead to morbidity and mortality.
本研究旨在探讨原花青素对肺移植后缺血再灌注损伤的预防作用。
本研究纳入12头猪(体重35±5千克),分为四组。第1组和第3组为对照组,行左肺上叶切除术。第2组和第4组为移植组,行左肺下叶切除术及异体移植术。仅第3组和第4组给予原花青素。对组织样本进行光学显微镜分析并记录组织病理学结果。
在包括充血(p = 0.565)、肺泡水肿(p = 0.197)和支气管周围炎症(p = 0.444)的组织病理学结果数值方面,对照组之间无统计学显著差异。然而,移植组之间急性细胞排斥反应的数值有统计学显著差异(p = 0.048)。第2组的平均氧化应激酶水平高于第4组;然而,差异无统计学显著性(p>0.05)。
根据我们实验研究的结果,基于原花青素对可能导致发病和死亡的缺血再灌注损伤的预防作用,其可安全用于肺移植。